122 related articles for article (PubMed ID: 32653591)
1. Type 2 diabetes mellitus decreases systemic exposure of clopidogrel active metabolite through upregulation of P-glycoprotein in rats.
Yao H; Gu J; Shan Y; Wang Y; Chen X; Sun D; Guo Y
Biochem Pharmacol; 2020 Oct; 180():114142. PubMed ID: 32653591
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Platelet Response to Clopidogrel in Zucker Diabetic Fatty Rats due to Impaired Clopidogrel Inactivation by Carboxylesterase 1 and Increased Exposure to Active Metabolite.
Yao H; Bai R; Ren T; Wang Y; Gu J; Guo Y
Drug Metab Dispos; 2019 Aug; 47(8):794-801. PubMed ID: 31092394
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics-induced disruption of gut microbiota increases systemic exposure of clopidogrel active metabolite in type 2 diabetic rats.
Chen X; Liu Y; Yao H; Song W; Song Y; Gu J; Guo Y
Drug Metab Dispos; 2022 Jul; ():. PubMed ID: 35858690
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters.
Wang Z; Yang H; Xu J; Zhao K; Chen Y; Liang L; Li P; Chen N; Geng D; Zhang X; Liu X; Liu L
Drug Metab Dispos; 2019 Oct; 47(10):1066-1079. PubMed ID: 31399507
[TBL] [Abstract][Full Text] [Related]
5. Decreased plasma exposure of clopidogrel active metabolite in rats after long-term treatment with clopidogrel.
Wang Y; Liu Y; Yao H; Chen X; Sun Y; Guo Y
Biopharm Drug Dispos; 2023 Apr; 44(2):129-136. PubMed ID: 36905582
[TBL] [Abstract][Full Text] [Related]
6. Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
Angiolillo DJ; Jakubowski JA; Ferreiro JL; Tello-Montoliu A; Rollini F; Franchi F; Ueno M; Darlington A; Desai B; Moser BA; Sugidachi A; Guzman LA; Bass TA
J Am Coll Cardiol; 2014 Sep; 64(10):1005-14. PubMed ID: 25190236
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein deficiency enhances metabolic activation of and platelet response to clopidogrel through marked up-regulation of Cyp3a11 in mice: Direct evidence for the interplay between P-glycoprotein and Cyp3a.
Ji JZ; Li YF; Jiang LP; Tai T; Ge PX; Mi QY; Zhu T; Xie HG
Biochem Pharmacol; 2021 Jan; 183():114313. PubMed ID: 33137324
[TBL] [Abstract][Full Text] [Related]
8. Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes.
Xu RJ; Kong WM; An XF; Zou JJ; Liu L; Liu XD
Front Pharmacol; 2020; 11():593982. PubMed ID: 33519456
[No Abstract] [Full Text] [Related]
9. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of arctigenin in normal and type 2 diabetic rats after oral and intravenous administration.
Zeng XY; Dong S; He NN; Jiang CJ; Dai Y; Xia YF
Fitoterapia; 2015 Sep; 105():119-26. PubMed ID: 26102179
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the potential drug-drug interaction between carvedilol and clopidogrel mediated through intestinal P-glycoprotein.
Incecayir T; Ilbasmis-Tamer S; Tirnaksiz F; Degim T
Pharmazie; 2016 Aug; 71(8):472-477. PubMed ID: 29442035
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved?
Yu S; Yu Y; Liu L; Wang X; Lu S; Liang Y; Liu X; Xie L; Wang G
Planta Med; 2010 Jun; 76(9):876-81. PubMed ID: 20108175
[TBL] [Abstract][Full Text] [Related]
13. Combined contributions of impaired hepatic CYP2C11 and intestinal breast cancer resistance protein activities and expression to increased oral glibenclamide exposure in rats with streptozotocin-induced diabetes mellitus.
Liu H; Liu L; Li J; Mei D; Duan R; Hu N; Guo H; Zhong Z; Liu X
Drug Metab Dispos; 2012 Jun; 40(6):1104-12. PubMed ID: 22393122
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic understanding of the effect of Dengzhan Shengmai capsule on the pharmacokinetics of clopidogrel in rats.
Chen X; Zhao Z; Chen Y; Gou X; Zhou Z; Zhong G; Cai Y; Huang M; Jin J
J Ethnopharmacol; 2016 Nov; 192():362-369. PubMed ID: 27459888
[TBL] [Abstract][Full Text] [Related]
15. Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.
Xu D; Li F; Zhang M; Zhang J; Liu C; Hu MY; Zhong ZY; Jia LL; Wang DW; Wu J; Liu L; Liu XD
Acta Pharmacol Sin; 2014 Sep; 35(9):1215-25. PubMed ID: 25152023
[TBL] [Abstract][Full Text] [Related]
16. Impact of P-glycoprotein on clopidogrel absorption.
Taubert D; von Beckerath N; Grimberg G; Lazar A; Jung N; Goeser T; Kastrati A; Schömig A; Schömig E
Clin Pharmacol Ther; 2006 Nov; 80(5):486-501. PubMed ID: 17112805
[TBL] [Abstract][Full Text] [Related]
17. Effect of Stay-Green Wheat, a Novel Variety of Wheat in China, on Glucose and Lipid Metabolism in High-Fat Diet Induced Type 2 Diabetic Rats.
Ji J; Zhang C; Luo X; Wang L; Zhang R; Wang Z; Fan D; Yang H; Deng J
Nutrients; 2015 Jun; 7(7):5143-55. PubMed ID: 26132991
[TBL] [Abstract][Full Text] [Related]
18. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
Hu N; Xie S; Liu L; Wang X; Pan X; Chen G; Zhang L; Liu H; Liu X; Liu X; Xie L; Wang G
Drug Metab Dispos; 2011 Mar; 39(3):419-25. PubMed ID: 21135265
[TBL] [Abstract][Full Text] [Related]
19. Darapladib inhibits atherosclerosis development in type 2 diabetes mellitus Sprague-Dawley rat model.
Wihastuti TA; Heriansyah T; Hanifa H; Andarini S; Sholichah Z; Sulfia YH; Adam AA; Refialdinata J; Lutfiana NC
Endocr Regul; 2018 Apr; 52(2):69-75. PubMed ID: 29715185
[TBL] [Abstract][Full Text] [Related]
20. What kinds of substrates show P-glycoprotein-dependent intestinal absorption? Comparison of verapamil with vinblastine.
Ogihara T; Kamiya M; Ozawa M; Fujita T; Yamamoto A; Yamashita S; Ohnishi S; Isomura Y
Drug Metab Pharmacokinet; 2006 Jun; 21(3):238-44. PubMed ID: 16858128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
